Home Berita Dalam Negeri ATS Reports Third Quarter Fiscal 2025 Results

ATS Reports Third Quarter Fiscal 2025 Results

2


Breadcrumb Trail Links

Business Wire News ReleasesPMN Press Releases

Article content

CAMBRIDGE, Ontario — ATS Corporation (TSX and NYSE: ATS) (“ATS” or the “Company”) today reported its financial results for the three and nine months ended December 29, 2024. All references to “$” or “dollars” in this news release are to Canadian dollars unless otherwise indicated.

Article content

Article content

Third quarter highlights:

Revenues were $652.0 million compared to $752.0 million a year ago.Net income was $6.5 million compared to $47.2 million a year ago.Basic earnings per share were 7 cents, compared to 48 cents a year ago.Adjusted EBITDA1 was $87.5 million compared to $119.3 million a year ago.Adjusted basic earnings per share1 were 32 cents compared to 65 cents a year ago.Order Bookings2 were $883 million, 32.2% higher compared to $668 million a year ago.Order Backlog2 was $2,060 million, 8.0% higher compared to $1,907 million a year ago.

Advertisement 2

Article content

“Today ATS reported third quarter results for fiscal ’25. Order Bookings this quarter reflected strong organic growth and contributions from our acquisitions,” said Andrew Hider, Chief Executive Officer. “As anticipated, third quarter results were impacted by lower revenues as a result of reduced market demand in the North American EV market, partially offset by strong and diversified growth in life sciences and food and beverage.”

Year-to-date highlights:

Revenues were $1,959.0 million compared to $2,241.4 million a year ago.Net Income was $40.9 million compared to $145.7 million a year ago.Basic earnings per share were 42 cents, compared to $1.49 a year ago.Adjusted EBITDA1 was $271.8 million compared to $354.6 million a year ago.Adjusted basic earnings per share1 were $1.07 compared to $1.96 a year ago.Order Bookings1 were $2,442 million, compared to $2,100 million a year ago.

Mr. Hider added: “Q3 was the second highest bookings quarter in company history. As we transition into the final quarter of the fiscal year and look ahead to fiscal 2026, our significant Order Backlog provides good revenue visibility and a solid foundation for ATS to drive customer and shareholder value creation.”

1 Non-IFRS measure: see “Non-IFRS and Other Financial Measures”.

2 Supplementary financial measure: see “Non-IFRS and Other Financial Measures”.

Financial results

(In millions of dollars, except per share and margin data)

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Variance

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Variance

Revenues

$

652.0

$

752.0

(13.3)%

$

1,959.0

$

2,241.4

(12.6)%

Net income

$

6.5

$

47.2

(86.2)%

$

40.9

$

145.7

(71.9)%

Adjusted earnings from operations1

$

65.7

$

101.2

(35.1)%

$

208.3

$

301.6

(30.9)%

Adjusted earnings from operations margin2

10.1%

13.5%

(338)bps

10.6%

13.5%

(282)bps

Adjusted EBITDA1

$

87.5

$

119.3

(26.7)%

$

271.8

$

354.6

(23.4)%

Adjusted EBITDA margin2

13.4%

15.9%

(244)bps

13.9%

15.8%

(195)bps

Basic earnings per share

$

0.07

$

0.48

(85.4)%

$

0.42

$

1.49

(71.8)%

Adjusted basic earnings per share1

$

0.32

$

0.65

(50.8)%

$

1.07

$

1.96

(45.4)%

Order Bookings3

$

883

$

668

32.2%

$

2,442

$

2,100

16.3%

As At

December 29
2024

December 31
2023

Variance

Order Backlog3

$

2,060

$

1,907

8.0%

1 Non-IFRS financial measure – See “Non-IFRS and Other Financial Measures”.

2 Non-IFRS ratio – See “Non-IFRS and Other Financial Measures”.

3 Supplementary financial measure – See “Non-IFRS and Other Financial Measures”.

Advertisement 3

Article content

Recent Acquisitions

On July 24, 2024, the Company acquired Paxiom Group (“Paxiom”). With headquarters in Montreal, Canada, Paxiom is a provider of primary, secondary, and end-of-line packaging machines in the food & beverage, cannabis, and pharmaceutical industries. Paxiom’s product line is expected to complement ATS’ packaging and food technology businesses and allow ATS to offer complete packaging and end-of-line solutions. The total purchase price paid (based on finalization of post-closing adjustments) was $146.4 million.

On August 30, 2024, the Company acquired all material assets of Heidolph Instruments GmbH & Co. KG and Hans Heidolph GmbH (“Hiedolph”), a leading manufacturer of premium lab equipment for the life sciences and pharmaceutical industries, with headquarters in Schwabach, Germany and facilities in the United States (“U.S.”), South Korea and China. The purchase price paid in the second quarter of fiscal 2025 was $45.1 million ($30.3 million Euros).

Third quarter summary

Third quarter of fiscal 2025 revenues were 13.3% or $100.0 million lower than in the corresponding period a year ago, primarily reflecting a year-over-year decrease in organic revenue (excluding contributions from acquired companies and foreign exchange translation) of $151.8 million or 20.2%, partially offset by revenues earned by acquired companies of $41.5 million, which included $18.7 million from Heidolph and $13.2 million from Paxiom. Revenues generated from construction contracts decreased 29.2% or $141.6 million from the prior period due to lower Order Backlog entering the period, primarily within the transportation market which included several large electric vehicle (“EV”) Order Bookings a year ago. Revenues from services increased 3.3% or $5.0 million, primarily due to revenues earned by acquired companies of $4.8 million. Revenues from the sale of goods increased 32.2% or $36.6 million primarily due to revenues earned by acquired companies of $26.2 million, most notably from Avidity Science, LLC (“Avidity”), in addition to organic revenue growth on higher Order Backlog entering the period.

By market, revenues generated in life sciences increased $59.3 million or 18.7% year over year. This was primarily due to contributions from acquisitions totalling $28.3 million, notably from Avidity, and organic revenue growth on higher Order Backlog entering the quarter. Revenues generated in food & beverage increased $18.4 million or 19.4% from the corresponding period last year due to contributions from acquisitions of $13.2 million and organic revenue growth on higher Order Backlog entering the quarter. Revenues in transportation decreased $190.6 million or 79.3% year over year, due to lower Order Backlog entering the quarter, as the prior year included several large EV projects. Revenues generated in consumer products increased $16.2 million or 23.5% year over year due to higher Order Backlog entering the quarter, and execution on increased in-quarter Order Bookings compared to the previous quarter. Revenues in energy decreased $3.3 million or 10.7% due to timing of program execution.

Article content

Advertisement 4

Article content

Net income for the third quarter of fiscal 2025 was $6.5 million (7 cents per share basic), compared to net income of $47.2 million (48 cents per share basic) for the third quarter of fiscal 2024. The decrease primarily reflected lower revenues, and higher selling, general, and administrative (“SG&A”), partially offset by increased gross margin profitability and lower restructuring costs. Adjusted basic earnings per share were 32 cents compared to 65 cents in the third quarter of fiscal 2024 (adjusted basic earnings per share is a non-IFRS financial measure — see “Non-IFRS and Other Financial Measures” and “Reconciliation of Non-IFRS Measures to IFRS Measures”).

Depreciation and amortization expense was $37.9 million in the third quarter of fiscal 2025, compared to $35.2 million a year ago.

Order Backlog Continuity

(In millions of dollars)

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Opening Order Backlog

$

1,824

$

2,016

$

1,793

$

2,153

Revenues

(652)

(752)

(1,959)

(2,241)

Order Bookings

883

668

2,442

2,100

Order Backlog adjustments1

5

(25)

(216)

2

(105)

Total

$

2,060

$

1,907

$

2,060

$

1,907

1 Order Backlog adjustments include incremental Order Backlog of acquired companies ($12 million acquired with Paxiom in the nine months ended December 29, 2024, and $4 million acquired with Avidity in the three and nine months ended December 31, 2023), foreign exchange adjustments, scope changes and cancellations.2 See Management’s Discussion and Analysis for the three and six months ended September 29, 2024 (“Q2F25 MD&A”).

Advertisement 5

Article content

Order Bookings

Third quarter of fiscal 2025 Order Bookings were $883 million, a 32.2% year-over-year increase, reflecting an increase of 21.9% in organic Order Bookings growth, in addition to 8.2% of growth from acquired companies and 2.1% from positive foreign exchange translation impacts. Order Bookings from acquired companies totalled $54.5 million. By market, Order Bookings in life sciences increased compared to the prior-year period primarily due to organic growth, along with $35.8 million of contributions from acquired companies, including $23.2 million from Heidolph. Order Bookings in food & beverage increased from the prior period due to contributions from acquired companies of $18.8 million. Order Bookings in transportation increased compared to the prior-year period due to timing of customer projects. Order Bookings in consumer products increased from the prior period primarily due to the timing of customer projects. Order Bookings in energy increased compared to the prior-year period primarily due to timing of customer projects.

Trailing twelve month book-to-bill ratio at December 29, 2024 was 1.18:1. Book-to-bill ratio, Order Bookings and organic Order Bookings growth are supplementary financial measures — see “Non-IFRS and Other Financial Measures.”

Backlog

At December 29, 2024, Order Backlog was $2,060 million, 8.0% higher than at December 31, 2023, primarily on account of higher Order Backlog in life sciences, consumer products, food & beverage and energy markets, partially offset by lower Order Backlog within the transportation market which included several large EV Order Bookings a year ago.

Outlook

The life sciences funnel remains strong, with a focus on strategic submarkets of pharmaceuticals, radiopharmaceuticals, and medical devices. Management continues to identify opportunities with both new and existing customers, including those who produce auto-injectors and wearable devices for diabetes and obesity treatments, contact lenses and pre-filled syringes, automated pharmacy solutions, as well as opportunities to provide life science solutions that leverage integrated capabilities from across ATS. Funnel activity in food & beverage remains strong. The Company continues to benefit from strong brand recognition within the global tomato processing, other soft fruits processing and vegetable processing industries, and there is continued interest in automated solutions within the food & beverage market more broadly. In transportation, the funnel consists of smaller opportunities relative to the size of the Order Bookings received throughout fiscal years 2023 and 2024 as North American industry participants continue to moderate new capacity investment to match end market demand and reduce platform costs. See “Update on Large EV Customer” below. Funnel activity in consumer products is stable, although discretionary spending by consumers, influenced by factors such as inflationary pressures, may impact timing of some customer investments in the Company’s solutions. Funnel activity in energy remains strong and includes longer-term opportunities in the nuclear industry. The Company is focused on clean energy applications including solutions for the refurbishment of nuclear power plants, early participation in the small modular reactor market, and grid battery storage.

Advertisement 6

Article content

Funnel growth in markets where environmental, social and governance requirements are an increasing focus for customers — including nuclear and grid battery storage, as well as consumer goods packaging — provide ATS with opportunities to use its capabilities to respond to customer sustainability standards and goals, including global and regional requirements to reduce carbon emissions. Customers seeking to de-risk or enhance the resiliency of their supply chains, address a shortage of skilled workers or combat higher labour costs also provide future opportunities for ATS to pursue. Management believes that the underlying trends driving customer demand for ATS solutions including rising labour costs, labour shortages, production onshoring or reshoring and the need for scalable, high-quality, energy-efficient production remain favourable.

Order Backlog of $2,060 million is expected to help mitigate some of the impact of quarterly variability in Order Bookings on revenues in the short term. The Company’s Order Backlog includes several large enterprise programs that have longer periods of performance and therefore longer revenue recognition cycles, particularly in life sciences. In the fourth quarter of fiscal 2025, management expects to generate revenues in the range of $650 million to $710 million. This estimate is calculated each quarter based on management’s assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity. In the short-term, management expects lower transportation revenues to continue to negatively impact margins, until reorganization actions are fully implemented.

Supplier lead times are generally acceptable across key categories; however, inflationary or other cost increases, price and lead-time volatility have and may continue to disrupt the timing and progress of the Company’s margin expansion efforts and affect revenue recognition. Over time, achieving management’s margin target assumes that the Company will successfully implement its margin expansion initiatives, and that such initiatives will result in improvements to its adjusted earnings from operations margin that offset these shorter-term pressures (see “Forward-Looking Statements” for a description of the risks underlying the achievement of the margin target in future periods).

Advertisement 7

Article content

The timing of customer decisions on larger opportunities is expected to cause variability in Order Bookings from quarter to quarter, and may be influenced as a result of tariffs. Revenues in a given period are dependent on a combination of the volume of outstanding projects the Company is contracted to perform, the size and duration of those projects, and the timing of project activities including design, assembly, testing, and installation. Given the specialized nature of the Company’s offerings, the size and scope of projects vary based on customer needs. The Company seeks to achieve revenue growth organically and by identifying strategic acquisition opportunities that provide access to attractive end-markets and new products and technologies and deliver hurdle-rate returns. After-sales revenues and reoccurring revenues, which ATS defines as revenues from ancillary products and services associated with equipment sales, and revenues from customers who purchase non-customized ATS product at regular intervals, are expected to provide some balance to customers’ capital expenditure cycles.

The Company continues to make progress in line with its plans to integrate acquired companies, and expects to realize cost and revenue synergies consistent with announced integration plans.

Advertisement 8

Article content

Reorganization Activities

In the third quarter of fiscal 2025, restructuring expenses of $3.3 million were recorded in relation to the Company’s previously disclosed reorganization activities. For the nine months ended December 29, 2024, total costs of $20.4 million were recorded.

Update on Large EV Customer

As disclosed in the Company’s Q2F25 MD&A, management has been, and continues to be, engaged in discussions with a particular customer of certain large EV programs with respect to outstanding payments owed and completing the commissioning of these projects in order to receive final milestone payments. While work remains paused on these projects, management has been and continues to be focused on efforts to resolve disagreements with the customer. The Company is prepared to consider all legal avenues available to it, including dispute resolution mechanisms and litigation, if necessary (see “Risk Factors”).

The Company has outstanding and overdue accounts receivable of approximately $165 million from this customer and approximately $175 million of contract assets reflecting work completed and remaining to be invoiced. Foreign currency revaluation drove the change in these amounts compared to the values disclosed in the Company’s Q2F25 MD&A. The Company believes that it has fulfilled its obligations under the contracts with this customer and that it is owed these amounts for work completed.

Tariffs

Risk Factors

Risks applicable to ATS’ business operations are described in the Company’s AIF under “Risk Factors.” The AIF is available on SEDAR+ at www.sedarplus.com and on the U.S. Securities Exchange Commission’s EDGAR at www.sec.gov. Such risks described in the AIF remain substantially unchanged. In addition, with respect to the information provided in “Update on Large EV Customer” herein, the risks titled “Litigation risk” and “Customer concentration risk” in the AIF specifically apply and are supplemented by an additional “Customer disagreement risk” in the Company’s management’s discussion and analysis for the third quarter of fiscal 2025 (the “Q3F25 MD&A”) (see “Risk Factors” in the Q3F25 MD&A). In addition, the risk titled “International trade risk” in the AIF is supplemented as described in the Q3F25 MD&A.

Advertisement 9

Article content

Quarterly Conference Call

ATS will host a conference call and webcast at 8:30 a.m. eastern on Wednesday, February 5, 2025 to discuss its quarterly results. The listen-only webcast can be accessed live at www.atsautomation.com. The conference call can be accessed live by dialing (888) 660-6652 or (646) 960-0554 five minutes prior. A replay of the conference will be available on the ATS website following the call. Alternatively, a telephone recording of the call will be available for one week (until midnight February 12, 2025) by dialing (800) 770-2030 and using the access code 8782510.

About ATS

ATS Corporation is an industry-leading automation solutions provider to many of the world’s most successful companies. ATS uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added solutions including pre-automation and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, transportation, food & beverage, consumer products, and energy. Founded in 1978, ATS employs over 7,500 people at more than 65 manufacturing facilities and over 85 offices in North America, Europe, Asia and Oceania. The Company’s common shares are traded on the Toronto Stock Exchange (“TSX”) and the New York Stock Exchange (“NYSE”) under the symbol ATS. Visit the Company’s website at www.atsautomation.com.

Consolidated Revenues

(In millions of dollars)

Revenues by type

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Revenues from construction contracts

$

343.6

$

485.2

$

1,056.0

$

1,473.8

Services rendered

158.0

153.0

491.8

444.4

Sale of goods

150.4

113.8

411.2

323.2

Total revenues

$

652.0

$

752.0

$

1,959.0

$

2,241.4

Revenues by market

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months

Ended
December 31,
2023

Life Sciences

$

376.1

$

316.8

$

1,054.9

$

893.3

Food & Beverage

113.3

94.9

304.0

335.3

Transportation

49.8

240.4

263.4

711.2

Consumer Products

85.2

69.0

246.4

217.2

Energy

27.6

30.9

90.3

84.4

Total revenues

$

652.0

$

752.0

$

1,959.0

$

2,241.4

Consolidated Operating Results

(In millions of dollars)

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Earnings from operations

$

33.1

$

78.5

$

122.8

$

240.6

16.1

17.1

51.2

51.8

1.0

0.9

3.2

2.1

2.1

0.8

3.8

0.8

Gain on sale of facilities

(11.7

)

(11.7

)

Restructuring charges

3.3

16.2

20.4

16.2

Settlement costs

8.7

8.7

Mark to market portion of stock-based compensation

1.4

(0.6

)

(1.8

)

1.8

Adjusted earnings from operations1

$

65.7

$

101.2

$

208.3

$

301.6

1 Non-IFRS Financial Measure, See “Non-IFRS and Other Financial Measures”

Advertisement 10

Article content

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Earnings from operations

$

33.1

$

78.5

$

122.8

$

240.6

Depreciation and amortization

37.9

35.2

114.7

104.8

EBITDA1

$

71.0

$

113.7

$

237.5

$

345.4

Restructuring charges

3.3

16.2

20.4

16.2

1.0

0.9

3.2

2.1

2.1

0.8

3.8

0.8

Settlement costs

8.7

8.7

Mark to market portion of stock-based compensation

1.4

(0.6

)

(1.8

)

1.8

Gain on sale of facilities

(11.7

)

(11.7

)

Adjusted EBITDA1

$

87.5

$

119.3

$

271.8

$

354.6

1 Non-IFRS Financial Measure, See “Non-IFRS and Other Financial Measures”

Order Backlog by Market

(In millions of dollars)

As at

December 29
2024

December 31
2023

Life Sciences

$

1,220

$

875

Food & Beverage

252

207

Transportation

250

564

Consumer Products

180

161

Energy

158

100

Total

$

2,060

$

1,907

Reconciliation of Non-IFRS Measures to IFRS Measures
(In millions of dollars, except per share data)

The following table reconciles adjusted EBITDA and EBITDA to the most directly comparable IFRS measure (net income):

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Adjusted EBITDA

$

87.5

$

119.3

$

271.8

$

354.6

Less: restructuring charges

3.3

16.2

20.4

16.2

1.0

0.9

3.2

2.1

2.1

0.8

3.8

0.8

Settlement costs

8.7

8.7

Less: mark to market portion of stock-based compensation

1.4

(0.6

)

(1.8

)

1.8

Less: gain on sale of facilities

(11.7

)

(11.7

)

EBITDA

$

71.0

$

113.7

$

237.5

$

345.4

Less: depreciation and amortization expense

37.9

35.2

114.7

104.8

Earnings from operations

$

33.1

$

78.5

$

122.8

$

240.6

Less: net finance costs

22.5

17.5

65.5

49.9

Less: provision for income taxes

4.1

13.8

16.4

45.0

Net income

$

6.5

$

47.2

$

40.9

$

145.7

The following table reconciles adjusted earnings from operations, adjusted net income, and adjusted basic earnings per share to the most directly comparable IFRS measures (net income (loss) and basic earnings (loss) per share):

Three Months Ended December 29, 2024

Three Months Ended December 31, 2023

Earnings
from
operations

Finance
costs

Provision
for income
taxes

Net
income

Basic
EPS

Earnings
from
operations

Finance
costs

Provision
for income
taxes

Net
income

Basic
EPS

Reported (IFRS)

$

33.1

$

(22.5

)

$

(4.1

)

$

6.5

$

0.07

$

78.5

$

(17.5

)

$

(13.8

)

$

47.2

$

0.48

16.1

16.1

0.17

17.1

17.1

0.17

Restructuring charges

3.3

3.3

0.03

16.2

16.2

0.16

2.1

2.1

0.02

0.8

0.8

0.01

1.0

1.0

0.01

0.9

0.9

0.01

Settlement costs

8.7

8.7

0.09

Mark to market portion of stock-based compensation

1.4

1.4

0.01

(0.6

)

(0.6

)

(0.01

)

Gain on sale of facilities

(11.7

)

(11.7

)

(0.11

)

Tax effect of the above adjustments1

(8.2

)

(8.2

)

(0.08

)

(6.0

)

(6.0

)

(0.06

)

Adjusted (non-IFRS)

$

65.7

$

30.9

$

0.32

$

101.2

$

63.9

$

0.65

1 Adjustments to provision for income taxes relate to the income tax effects of adjustment items that are excluded for the purposes of calculating non-IFRS based adjusted net income.

Advertisement 11

Article content

Nine Months Ended December 29, 2024

Nine Months Ended December 31, 2023

Earnings
from
operations

Finance
costs

Provision
for income
taxes

Net
income

Basic
EPS

Earnings
from
operations

Finance
costs

Provision
for income
taxes

Net
income

Basic
EPS

Reported (IFRS)

$

122.8

$

(65.5

)

$

(16.4

)

$

40.9

$

0.42

$

240.6

$

(49.9

)

$

(45.0

)

$

145.7

$

1.49

51.2

51.2

0.52

51.8

51.8

0.53

Restructuring charges

20.4

20.4

0.21

16.2

16.2

0.17

3.8

3.8

0.04

0.8

0.8

0.01

3.2

3.2

0.03

2.1

2.1

0.02

Settlement costs

8.7

8.7

0.09

Mark to market portion of stock-based compensation

(1.8

)

(1.8

)

(0.02

)

1.8

1.8

0.02

Gain on sale of facilities

(11.7

)

(11.7

)

(0.12

)

Tax effect of the above adjustments1

(22.0

)

(22.0

)

(0.22

)

(15.6

)

(15.6

)

(0.16

)

Adjusted (non-IFRS)

$

208.3

$

104.4

$

1.07

$

301.6

$

191.1

$

1.96

1 Adjustments to provision for income taxes relate to the income tax effects of adjustment items that are excluded for the purposes of calculating non-IFRS based adjusted net income.

The following table reconciles organic revenue to the most directly comparable IFRS measure (revenue):

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Organic revenue

$

600.2

$

706.2

$

1,820.8

$

2,096.5

Revenues of acquired companies

41.5

29.7

112.3

59.5

Impact of foreign exchange rate changes

10.3

16.1

25.9

85.4

Total revenue

$

652.0

$

752.0

$

1,959.0

$

2,241.4

Organic revenue growth

(20.2

)%

(18.8

)%

The following table reconciles non-cash working capital as a percentage of revenues to the most directly comparable IFRS measures:

As at

December 29
2024

March 31
2024

Accounts receivable

$

709.1

$

471.3

Income tax receivable

17.7

13.4

Contract assets

619.5

704.7

Inventories

366.2

295.9

Deposits, prepaids and other assets

98.9

98.2

Accounts payable and accrued liabilities

(629.8

)

(604.5

)

Income tax payable

(34.0

)

(44.7

)

Contract liabilities

(346.3

)

(312.2

)

Provisions

(35.7

)

(36.0

)

Non-cash working capital

$

765.6

$

586.1

Trailing six-month revenues annualized

$

2,529.5

$

3,087.0

Working capital %

30.3

%

19.0

%

The following table reconciles net debt to the most directly comparable IFRS measures:

As at

December 29
2024

March 31
2024

Cash and cash equivalents

$

263.2

$

170.2

Bank indebtedness

(4.3

)

(4.1

)

Current portion of lease liabilities

(30.7

)

(27.6

)

Current portion of long-term debt

(0.2

)

(0.2

)

Long-term lease liabilities

(96.4

)

(83.8

)

Long-term debt

(1,611.0

)

(1,171.8

)

Net Debt

$

(1,479.4

)

$

(1,117.3

)

Pro Forma Adjusted EBITDA (TTM)

$

397.4

$

485.3

Net Debt to Pro Forma Adjusted EBITDA

3.7x

2.3x

Advertisement 12

Article content

The following table reconciles free cash flow to the most directly comparable IFRS measures:

(in millions of dollars)

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Cash flows provided by (used in) operating activities

$

66.7

$

110.5

$

(13.5

)

$

11.2

Acquisition of property, plant and equipment

(6.9

)

(12.0

)

(22.1

)

(46.5

)

Acquisition of intangible assets

(9.5

)

(5.7

)

(27.0

)

(16.0

)

Free cash flow

$

50.3

$

92.8

$

(62.6

)

$

(51.3

)

Certain non-IFRS financial measures exclude the impact on stock-based compensation expense of the revaluation of deferred share units and restricted share units resulting specifically from the change in market price of the Company’s common shares between periods. Management believes the adjustment provides further insight into the Company’s performance.

The following table reconciles total stock-based compensation expense to its components:

(in millions of dollars)

Q3 2025

Q2 2025

Q1 2025

Q4 2024

Q3 2024

Q2 2024

Q1 2024

Q4 2023

Total stock-based compensation expense

$

5.1

$

2.7

$

3.7

$

(4.3

)

$

4.7

$

3.5

$

10.0

$

19.3

Less: Mark to market portion of stock-based compensation

1.4

(1.9

)

(1.3

)

(8.5

)

(0.6

)

(2.0

)

4.4

15.1

Base stock-based compensation expense

$

3.7

$

4.6

$

5.0

$

4.2

$

5.3

$

5.5

$

5.6

$

4.2

INVESTMENTS, LIQUIDITY, CASH FLOW AND FINANCIAL RESOURCES

(In millions of dollars, except ratios)

As at

December 29
2024

March 31
2024

Cash and cash equivalents

$

263.2

$

170.2

Debt-to-equity ratio1

1.08:1

0.79:1

1 Debt is calculated as bank indebtedness, long-term debt and lease liabilities. Equity is calculated as total equity less accumulated other comprehensive income.

Three Months
Ended
December 29,
2024

Three Months
Ended
December 31,
2023

Nine Months
Ended
December 29,
2024

Nine Months
Ended
December 31,
2023

Cash, beginning of period

$

246.9

$

187.4

$

170.2

$

159.9

Total cash provided by (used in):

Operating activities

66.7

110.5

(13.5

)

11.2

Investing activities

(30.3

)

(269.3

)

(243.9

)

(315.5

)

Financing activities

(21.6

)

232.8

344.6

406.1

Net foreign exchange difference

1.5

(0.5

)

5.8

(0.8

)

Cash, end of period

$

263.2

$

260.9

$

263.2

$

260.9

ATS CORPORATION

Interim Condensed Consolidated Statements of Financial Position

(in thousands of Canadian dollars – unaudited)

As at

December 29
2024

March 31
2024

ASSETS

Current assets

Cash and cash equivalents

$

263,152

$

170,177

Accounts receivable

709,127

471,345

Income tax receivable

17,668

13,428

Contract assets

619,510

704,703

Inventories

366,207

295,880

Deposits, prepaids and other assets

98,935

98,161

2,074,599

1,753,694

Non-current assets

Property, plant and equipment

320,133

296,977

Right-of-use assets

120,209

105,661

Other assets

3,123

18,416

Goodwill

1,369,149

1,228,600

Intangible assets

754,600

679,547

Deferred income tax assets

24,500

5,904

2,591,714

2,335,105

Total assets

$

4,666,313

$

4,088,799

LIABILITIES AND EQUITY

Current liabilities

Bank indebtedness

$

4,252

$

4,060

Accounts payable and accrued liabilities

629,824

604,488

Income tax payable

33,998

44,732

Contract liabilities

346,271

312,204

Provisions

35,749

35,978

Current portion of lease liabilities

30,688

27,571

Current portion of long-term debt

193

176

1,080,975

1,029,209

Non-current liabilities

Employee benefits

26,262

24,585

Long-term lease liabilities

96,390

83,808

Long-term debt

1,611,039

1,171,796

Deferred income tax liabilities

86,661

81,353

Other long-term liabilities

8,946

14,101

1,829,298

1,375,643

Total liabilities

$

2,910,273

$

2,404,852

EQUITY

Share capital

$

841,559

$

865,897

Contributed surplus

35,982

26,119

Accumulated other comprehensive income

145,608

64,155

Retained earnings

729,346

724,495

Equity attributable to shareholders

1,752,495

1,680,666

Non-controlling interests

3,545

3,281

Total equity

1,756,040

1,683,947

Total liabilities and equity

$

4,666,313

$

4,088,799

Advertisement 13

Article content

Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company’s profile on SEDAR+ at www.sedarplus.com, the Company’s profile on the U.S. Securities and Exchange Commission’s website at www.sec.gov, and on the Company’s website at www.atsautomation.com.

ATS CORPORATION

Interim Condensed Consolidated Statements of Income

(in thousands of Canadian dollars, except per share amounts – unaudited)

Three months ended

Nine months ended

December 29
2024

December 31
2023

December 29
2024

December 31
2023

Revenues

$

651,993

$

752,052

$

1,959,044

$

2,241,417

Operating costs and expenses

Cost of revenues

454,061

538,435

1,374,193

1,606,658

Selling, general and administrative

156,365

114,187

430,025

359,811

Restructuring costs

3,360

16,228

20,435

16,228

Stock-based compensation

5,125

4,671

11,548

18,116

Earnings from operations

33,082

78,531

122,843

240,604

Net finance costs

22,440

17,537

65,492

49,945

Income before income taxes

10,642

60,994

57,351

190,659

Income tax expense

4,137

13,812

16,438

45,010

Net income

$

6,505

$

47,182

$

40,913

$

145,649

Attributable to

Shareholders

$

6,414

$

47,048

$

40,809

$

145,276

Non-controlling interests

91

134

104

373

$

6,505

$

47,182

$

40,913

$

145,649

Earnings per share attributable to shareholders

Basic

$

0.07

$

0.48

$

0.42

$

1.49

Diluted

$

0.07

$

0.47

$

0.41

$

1.48

Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company’s profile on SEDAR+ at www.sedarplus.com, the Company’s profile on the U.S. Securities and Exchange Commission’s website at www.sec.gov, and on the Company’s website at www.atsautomation.com.

ATS CORPORATION

Interim Condensed Consolidated Statements of Cash Flows

(in thousands of Canadian dollars – unaudited)

Three months ended

Nine months ended

December 29
2024

December 31
2023

December 29
2024

December 31
2023

Operating activities

Net income

$

6,505

$

47,182

$

40,913

$

145,649

Items not involving cash

Depreciation of property, plant and equipment

8,404

7,111

25,152

20,791

Amortization of right-of-use assets

8,563

7,304

24,967

21,656

Amortization of intangible assets

20,943

20,743

64,511

62,393

Deferred income taxes

(9,488

)

(8,693

)

(25,266

)

(9,020

)

Other items not involving cash

(1,605

)

(1,871

)

(2,666

)

(2,433

)

Stock-based compensation

3,281

3,043

9,907

8,146

Change in non-cash operating working capital

30,081

35,689

(151,073

)

(235,977

)

Cash flows provided by (used in) operating activities

$

66,684

$

110,508

$

(13,555

)

$

11,205

Investing activities

Acquisition of property, plant and equipment

$

(6,901

)

$

(12,045

)

$

(22,111

)

$

(46,516

)

Acquisition of intangible assets

(9,506

)

(5,666

)

(27,032

)

(15,971

)

Business acquisitions, net of cash acquired

2,280

(266,117

)

(179,389

)

(275,776

)

Settlement of cross-currency interest rate swap instrument

(16,555

)

(16,555

)

Proceeds from disposal of property, plant and equipment

350

14,554

1,135

22,809

Cash flows used in investing activities

$

(30,332

)

$

(269,274

)

$

(243,952

)

$

(315,454

)

Financing activities

Bank indebtedness

$

(13,559

)

$

2,495

$

(503

)

$

(378

)

Repayment of long-term debt

(218,569

)

(76,151

)

(505,686

)

(542,095

)

Proceeds from long-term debt

193,836

310,844

908,354

626,828

Settlement of cross-currency interest rate swap instrument

24,262

24,262

Proceeds from exercise of stock options

52

775

139

1,954

Proceeds from U.S. initial public offering, net of issuance fees

362,072

Purchase of non-controlling interest

13

(195

)

Repurchase of common shares

(44,983

)

Acquisition of shares held in trust

(14,690

)

(23,820

)

Principal lease payments

(7,678

)

(5,135

)

(22,244

)

(18,250

)

Cash flows provided by (used in) financing activities

$

(21,656

)

$

232,841

$

344,649

$

406,116

Effect of exchange rate changes on cash and cash equivalents

1,519

(569

)

5,833

(846

)

Increase in cash and cash equivalents

16,215

73,506

92,975

101,021

Cash and cash equivalents, beginning of period

246,937

187,382

170,177

159,867

Cash and cash equivalents, end of period

$

263,152

$

260,888

$

263,152

$

260,888

Supplemental information

Cash income taxes paid

$

21,797

$

7,946

$

51,213

$

33,662

Cash interest paid

$

23,147

$

20,814

$

62,837

$

54,952

Advertisement 14

Article content

Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company’s profile on SEDAR+ at www.sedarplus.com, the Company’s profile on the U.S. Securities and Exchange Commission’s website at www.sec.gov, and on the Company’s website at www.atsautomation.com.

Non-IFRS and Other Financial Measures

Throughout this document, management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company.

Advertisement 15

Article content

Following amendments to ATS’ RSU Plan in 2022 to provide the Company with the option for settlement in shares purchased in the open market and the creation of the employee benefit trust to facilitate such settlement, ATS began to account for equity-settled RSUs using the equity method of accounting. However, prior RSU grants which will be cash-settled and deferred share unit (“DSU”) grants which will be cash-settled are accounted for as described in the Company’s annual consolidated financial statements and have volatility period over period based on the fluctuating price of ATS’ common shares. Certain non-IFRS financial measures (adjusted EBITDA, net debt to pro forma adjusted EBITDA, adjusted earnings from operations and adjusted basic earnings per share) exclude the impact on stock-based compensation expense of the revaluation of DSUs and RSUs resulting specifically from the change in market price of the Company’s common shares between periods. Management believes that this adjustment provides insight into the Company’s performance, as share price volatility drives variability in the Company’s stock-based compensation expense.

Operating margin, adjusted earnings from operations, EBITDA, EBITDA margin, adjusted EBITDA, pro forma adjusted EBITDA and adjusted EBITDA margin are used by the Company to evaluate the performance of its operations. Management believes that earnings from operations is an important indicator in measuring the performance of the Company’s operations on a pre-tax basis and without consideration as to how the Company finances its operations. Management believes that organic revenue and organic revenue growth, when considered with IFRS measures, allow the Company to better measure the Company’s performance and evaluate long-term performance trends. Organic revenue growth also facilitates easier comparisons of the Company’s performance with prior and future periods and relative comparisons to its peers. Management believes that EBITDA and adjusted EBITDA are important indicators of the Company’s ability to generate operating cash flows to fund continued investment in its operations. Management believes that adjusted earnings from operations, adjusted earnings from operations margin, adjusted EBITDA, adjusted net income and adjusted basic earnings per share are important measures to increase comparability of performance between periods. The adjustment items used by management to arrive at these metrics are not considered to be indicative of the business’ ongoing operating performance. Management uses the measure “non-cash working capital as a percentage of revenues” to assess overall liquidity. Free cash flow is used by the Company to measure cash flow from operations after investment in property, plant and equipment and intangible assets. Management uses net debt to pro forma adjusted EBITDA as a measurement of leverage of the Company. Order Bookings provide an indication of the Company’s ability to secure new orders for work during a specified period, while Order Backlog provides a measure of the value of Order Bookings that have not been completed at a specified point in time. Both Order Bookings and Order Backlog are indicators of future revenues that the Company expects to generate based on contracts that management believes to be firm. Organic Order Bookings and organic Order Bookings growth allow the Company to better measure the Company’s performance and evaluate long-term performance trends. Organic Order Bookings growth also facilitates easier comparisons of the Company’s performance with prior and future periods and relative comparisons to its peers. Book to bill ratio is used to measure the Company’s ability and timeliness to convert Order Bookings into revenues. Management believes that ATS shareholders and potential investors in ATS use these additional IFRS measures and non-IFRS financial measures in making investment decisions and measuring operational results.

Advertisement 16

Article content

A reconciliation of (i) adjusted EBITDA and EBITDA to net income, (ii) adjusted earnings from operations to net income, (iii) adjusted net income to net income, (iv) adjusted basic earnings per share to basic earnings per share (v) free cash flow to its IFRS measure components and (vi) organic revenue to revenue, in each case for the three- and nine-months ended December 29, 2024 and December 31, 2023 is contained in this document (see “Reconciliation of Non-IFRS Measures to IFRS Measures”). This document also contains a reconciliation of (i) non-cash working capital as a percentage of revenues and (ii) net debt to their IFRS measure components, in each case at both December 29, 2024 and March 31, 2024 (see “Reconciliation of Non-IFRS Measures to IFRS Measures”). A reconciliation of Order Bookings and Order Backlog to total Company revenues for the three- and nine-months ended December 29, 2024 and December 31, 2023 is also contained in this news release (see “Order Backlog Continuity”).

Forward-Looking Statements

This news release contains certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws (“forward-looking statements”). All such statements are made pursuant to the “safe harbour” provisions of Canadian provincial and territorial securities laws and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts regarding possible events, conditions or results of operations that ATS believes, expects or anticipates will or may occur in the future, including, but not limited to: the value creation strategy; the Company’s strategy to expand organically and through acquisition, and the expected benefits to be derived; disciplined acquisitions; various market opportunities for ATS; expanding in emerging markets; expectation on transportation revenues, including the expected decrease in demand for the Company’s solutions in the EV space, and the allocation of resources to other markets; conversion of opportunities into Order Bookings; the announcement of new Order Bookings and the anticipated timeline for delivery; potential impacts on the time to convert opportunities into Order Bookings; the Company’s Order Backlog partially mitigating the impact of variable Order Bookings; the expected benefits where the Company engages with customers on enterprise-type solutions; the potential impact of the Company’s approach to market and timing of customer decisions on Order Bookings, performance period, and timing of revenue recognition; collection of payments from customers, including milestone payments relating to certain large EV programs; expected benefits with respect to the Company’s efforts to grow its product portfolio and after-sale service revenues; the ability of after-sales revenues and reoccurring revenues to provide some balance to customers’ capital expenditure cycles; initiatives in furtherance of the Company’s goal of improving its adjusted earnings from operations margin over the long term; the uncertainty of supply chain dynamics; the anticipated range of revenues for the following quarter; expectation of realization of cost and revenue synergies from integration of acquired businesses; non-cash working capital levels as a percentage of revenues in the short-term and the long-term; planned reorganization activities, including the reorganization activity implemented to reflect the expected decrease in demand for the Company’s solutions in the EV space, and its ability to improve the cost structure of the Company, and the expected timing and cost of the reorganization activities; expectation in relation to meeting liquidity and funding requirements for investments; potential to use debt or equity financing to support strategic opportunities and growth strategy; underlying trends driving customer demand; potential impacts of variability in bookings caused by the strategic nature and size of EV programs; revenue growth in other markets and due to acquisitions to offset any reduced volumes from the EV program in fiscal 2025; expected capital expenditures for fiscal 2025; the uncertainty and potential impact on the Company’s business and operations due to the current macroeconomic environment including the impacts of any epidemic or pandemic outbreak or resurgence, inflation, uncertainty caused by the supply chain dynamics, interest rate changes, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry generally, international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and regional conflicts; the Company’s potential consideration of any private dispute resolution process or litigation in connection with the existing disagreement with an EV customer; and the Company’s belief with respect to the outcome or impact of any lawsuits, claims, counterclaims and contingencies.

Advertisement 17

Article content

Advertisement 18

Article content

Forward-looking statements are necessarily based on a number of estimates, factors, and assumptions regarding, among others, management’s current plans, estimates, projections, beliefs and opinions, the future performance and results of the Company’s business and operations; the ability of ATS to execute on its business objectives; the effectiveness of ABM in accomplishing its goals; the ability to successfully implement margin expansion initiative; initiatives in furtherance of the Company’s goal of improving its adjusted earnings from operations margin over the long term; the anticipated growth in the life sciences, food & beverage, consumer products, and energy markets; the ability to seek out, enter into and successfully integrate acquisitions; ongoing cost inflationary pressures and the Company’s ability to respond to such inflationary pressures; the effects of foreign currency exchange rate fluctuations on its operations; the Company’s competitive position in the industry; the Company’s ability to adapt and develop solutions that keep pace with continuing changes in technology and customer needs; the ability to maintain mutually beneficial relationships with the Company’s customers; and general economic and political conditions, and global events, including any epidemic or pandemic outbreak or resurgence, and the international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and any escalation of such trade disputes.

Forward-looking statements included in this news release are only provided to understand management’s current expectations relating to future periods and, as such, are not appropriate for any other purpose. Although ATS believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and ATS cautions you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. ATS does not undertake any obligation to update forward-looking statements contained herein other than as required by law.

Certain forward-looking information included in this news release may also constitute a “financial outlook” within the meaning of applicable securities laws. Financial outlook involves statements about ATS’ prospective financial performance, financial position or cash flows that is based on and subject to the assumptions about future economic conditions and courses of action described above as well as management’s assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity. Such assumptions are based on management’s assessment of the relevant information currently available and any financial outlook included herein is provided for the purpose of helping readers understand management’s current expectations and plans for the future as of the date hereof. The actual results of ATS’ operations may vary from the amounts set forth in any financial outlook and such variances may be material. Readers are cautioned that reliance on any financial outlook may not be appropriate for other purposes or in other circumstances and that the risk factors described above and other factors may cause actual results to differ materially from any financial outlook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250205374000/en/

logo

Contacts

For more information, contact:
David Galison
Head of Investor Relations
ATS Corporation
730 Fountain Street North
Cambridge, ON, N3H 4R7
(519) 653-6500
dgalison@atsautomation.com

For general media inquiries, contact:
Matthew Robinson
Director, Corporate Communications
ATS Corporation
730 Fountain Street North
Cambridge, ON, N3H 4R7
(519) 653-6500
mrobinson@atsautomation.com

#distro

Article content

Share this article in your social network